Annual report [Section 13 and 15(d), not S-K Item 405]

Statement of Changes in Stockholders' Equity

v3.25.0.1
Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   8,009,743    
Beginning balance at Dec. 31, 2022 $ 2,374 $ 1 $ 24,559 $ (22,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 3,208   3,208  
Sale of Common Stock, net of issuance costs (in shares)   17,872,955    
Sale of Common Stock, net of issuance costs $ 24,764 $ 2 24,762  
Stock issuance upon exercise of stock options (in shares) 180,072 180,072    
Stock issuance upon exercise of stock options $ 214   214  
Stock issuance upon vesting of restricted stock units (in shares)   258,970    
Stock Issuance upon exercise of warrants (in shares) 1,471 7,292    
Stock Issuance upon exercise of warrants $ 16   16  
Net loss $ (14,639)     (14,639)
Ending balance (in shares) at Dec. 31, 2023 26,329,032 26,329,032    
Ending balance at Dec. 31, 2023 $ 15,937 $ 3 52,759 (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 4,299   4,299  
Sale of Common Stock, net of issuance costs (in shares)   309,634    
Sale of Common Stock, net of issuance costs $ 730   730  
Stock issuance upon exercise of stock options (in shares) 144,408 144,408    
Stock issuance upon exercise of stock options $ 136   136  
Stock issuance upon vesting of restricted stock units (in shares)   177,827    
Net loss $ (19,448)     (19,448)
Ending balance (in shares) at Dec. 31, 2024 26,329,032 26,960,901    
Ending balance at Dec. 31, 2024 $ 1,654 $ 3 $ 57,924 $ (56,273)